Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

What you need to know about the coronavirus right now

Published 15/02/2021, 04:30 pm

Feb 15 (Reuters) - Here's what you need to know about the coronavirus right now:

Vaccines touch down in Australia and New Zealand

Australia and New Zealand have received their first vaccine deliveries and will begin rolling out inoculations in the coming week, while Melbourne and Auckland remained locked down following the emergence of new cases.

"The eagle has landed," Australian Health Minister Greg Hunt told reporters in Canberra on Monday as the first shipment of 142,000 doses of the vaccine developed by Pfizer (NYSE:PFE) and Germany's BioNTech touched down.

Vaccinations in Australia will start from Feb. 22. vaccine 'extremely effective'

Israel's largest healthcare provider reported on Sunday a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of Pfizer's vaccine in the country's biggest study to date.

Health maintenance organization Clalit, which covers more than half of all Israelis, said the same group was also 92% less likely to develop severe illness from the virus.

"It shows unequivocally that Pfizer's coronavirus vaccine is extremely effective in the real world a week after the second dose, just as it was found to be in the clinical study," said Ran Balicer, Clalit's chief innovation officer. of UK lockdown?

British Prime Minister Boris Johnson will judge this week how fast England can exit lockdown after the United Kingdom vaccinated 15 million of its most vulnerable people, but the health minister said death and hospital admission numbers were still too high.

With nearly a quarter of the United Kingdom's population now inoculated with a first dose in a little over two months, Johnson is under pressure from some lawmakers and businesses to reopen the economy.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We've got to watch the data," Health Secretary Matt Hancock told Sky News. "Everybody wants to get out of this as quickly as we safely can, and both as quickly, but also as safely, are important." Korea cuts vaccination target

South Korea said on Monday it would not use AstraZeneca (NASDAQ:AZN)'s vaccine on people aged 65 and older, reversing an earlier decision, and scaled back initial vaccination targets due to delayed shipments from global vaccine-sharing scheme COVAX.

South Korea had said it would complete vaccinations on 1.3 million people by the first quarter of this year with AstraZeneca shots, but it slashed the target sharply to 750,000.

The decision is largely due to adjustments in the supply timetable of the 2.6 million doses of AstraZeneca vaccine from COVAX, the Korea Disease Control and Prevention Agency said. rush to ski, drink and party

Dancing, drinking and fighting marked the easing of some restrictions in Poland over the weekend as tourists, many without masks, let off steam in the ski resort of Zakopane.

Poland allowed ski slopes to reopen from Friday for a two-week trial period, with cinemas, theatres and hotels also allowed to open at a maximum of 50% capacity.

Polish authorities have warned that tighter restrictions will be reimposed if case numbers rise as a result of people disregarding social distancing rules.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.